These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2088206)

  • 1. Effect of a thymidine kinase inhibitor (L-653,180) on antiviral treatment of experimental herpes simplex virus infection in mice.
    Klein RJ; Czelusniak SM
    Antiviral Res; 1990; 14(4-5):207-14. PubMed ID: 2088206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of experimental latent herpes simplex virus infections with acyclovir and other antiviral compounds.
    Klein RJ
    Am J Med; 1982 Jul; 73(1A):138-42. PubMed ID: 6285703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleotide sequence of thymidine kinase gene of sequential acyclovir-resistant herpes simplex virus type 1 isolates recovered from a child with Wiskott-Aldrich syndrome: evidence for reactivation of acyclovir-resistant herpes simplex virus.
    Saijo M; Suzutani T; Itoh K; Hirano Y; Murono K; Nagamine M; Mizuta K; Niikura M; Morikawa S
    J Med Virol; 1999 Aug; 58(4):387-93. PubMed ID: 10421406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of acyclovir, oxetanocin-G, and carbocyclic oxetanocin-G in combinations on the replications of herpes simplex virus type 1 and type 2 in Vero cells.
    Saijo M; Suzutani T; Yoshida I
    Tohoku J Exp Med; 1992 May; 167(1):57-68. PubMed ID: 1333651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of latent infections in mice inoculated with herpes simplex virus which is clinically resistant to acyclovir.
    Field HJ; Lay E
    Antiviral Res; 1984 Apr; 4(1-2):43-52. PubMed ID: 6331304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel animal model for evaluating topical efficacy of antiviral agents: flux versus efficacy correlations in the acyclovir treatment of cutaneous herpes simplex virus type 1 (HSV-1) infections in hairless mice.
    Lee PH; Su MH; Kern ER; Higuchi WI
    Pharm Res; 1992 Aug; 9(8):979-89. PubMed ID: 1329068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of a selective inhibitor of herpes simplex virus thymidine kinase (L-653,180) as therapy for experimental recurrent genital herpes.
    Bourne N; Bravo FJ; Ashton WT; Meurer LC; Tolman RL; Karkas JD; Stanberry LR
    Antimicrob Agents Chemother; 1992 Sep; 36(9):2020-4. PubMed ID: 1329638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of a combination of ponicidin and acyclovir/ganciclovir to the antitumor efficacy of the herpes simplex virus thymidine kinase gene therapy system.
    Hayashi K; Hayashi T; Sun HD; Takeda Y
    Hum Gene Ther; 2002 Feb; 13(3):415-23. PubMed ID: 11860708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved radiosensitization of rat glioma cells with adenovirus-expressed mutant herpes simplex virus-thymidine kinase in combination with acyclovir.
    Valerie K; Brust D; Farnsworth J; Amir C; Taher MM; Hershey C; Feden J
    Cancer Gene Ther; 2000 Jun; 7(6):879-84. PubMed ID: 10880018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of oral treatment with acyclovir and bromovinyldeoxyuridine on the establishment of maintenance of latent herpes simplex virus infection in mice.
    Field HJ; De Clercq E
    J Gen Virol; 1981 Oct; 56(Pt 2):259-65. PubMed ID: 6273499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latent acyclovir-resistant herpes simplex virus type 1 in trigeminal ganglia of immunocompetent individuals.
    van Velzen M; van Loenen FB; Meesters RJ; de Graaf M; Remeijer L; Luider TM; Osterhaus AD; Verjans GM
    J Infect Dis; 2012 May; 205(10):1539-43. PubMed ID: 22457282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication.
    Field AK; Davies ME; DeWitt C; Perry HC; Liou R; Germershausen J; Karkas JD; Ashton WT; Johnston DB; Tolman RL
    Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4139-43. PubMed ID: 6306664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivo.
    Field HJ; Darby G
    Antimicrob Agents Chemother; 1980 Feb; 17(2):209-16. PubMed ID: 6247969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diverse herpes simplex virus type 1 thymidine kinase mutants in individual human neurons and Ganglia.
    Wang K; Mahalingam G; Hoover SE; Mont EK; Holland SM; Cohen JI; Straus SE
    J Virol; 2007 Jul; 81(13):6817-26. PubMed ID: 17459924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative activity of penciclovir and acyclovir in mice infected intraperitoneally with herpes simplex virus type 1 SC16.
    Sutton D; Boyd MR
    Antimicrob Agents Chemother; 1993 Apr; 37(4):642-5. PubMed ID: 8388195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acyclovir-resistant perineal HSV infection revealing chronic lymphoid leukaemia].
    Casassa EA; Nicol P; Viraben R; Gaudin C; Bulai Livideanu C; Mengelle C; Lamant L; Fortenfant F; Paul C; Konstantinou MP
    Ann Dermatol Venereol; 2018 Mar; 145(3):182-186. PubMed ID: 29221652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel resistance-associated mutations of thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 and type 2.
    Sauerbrei A; Bohn K; Heim A; Hofmann J; Weissbrich B; Schnitzler P; Hoffmann D; Zell R; Jahn G; Wutzler P; Hamprecht K
    Antivir Ther; 2011; 16(8):1297-308. PubMed ID: 22155911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prodrugs of herpes simplex thymidine kinase inhibitors.
    Yanachkova M; Xu WC; Dvoskin S; Dix EJ; Yanachkov IB; Focher F; Savi L; Sanchez MD; Foster TP; Wright GE
    Antivir Chem Chemother; 2015 Apr; 24(2):47-55. PubMed ID: 26463822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of a HSV thymidine kinase stimulating substance, scopadulciol, in improving the efficacy of cancer gene therapy.
    Hayashi K; Lee JB; Maitani Y; Toyooka N; Nemoto H; Hayashi T
    J Gene Med; 2006 Aug; 8(8):1056-67. PubMed ID: 16779868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Azone upon the in vivo antiviral efficacy of cidofovir or acyclovir topical formulations in treatment/prevention of cutaneous HSV-1 infections and its correlation with skin target site free drug concentration in hairless mice.
    Afouna MI; Fincher TK; Zaghloul AA; Reddy IK
    Int J Pharm; 2003 Mar; 253(1-2):159-68. PubMed ID: 12593946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.